Overexpression of amyloid precursor protein increases copper content in HEK293 cells

Biochemical and Biophysical Research Communications

Volumn 382, Issue 4, 2009, Pages 740-744

  Suazo, Miriam ^a   Hodar, Christian ^a   Morgan, Carlos ^a   Cerpa, Waldo ^b   Cambiazo, Verónica ^a   Inestrosa, Nibaldo C ^b   Gonzalez, Mauricio ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b MIFAB ^*  (Chile)

Author keywords

Alzheimer; Copper homeostasis; Reduction; Uptake; Yeast

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COPPER; NITRITE REDUCTASE;

ALZHEIMER DISEASE; ARTICLE; CELL LINE; CELL STRAIN HEK293; CELL VIABILITY; COPPER BLOOD LEVEL; COPPER METABOLISM; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SACCHAROMYCES CEREVISIAE; WILD TYPE;

AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE; COPPER; HOMEOSTASIS; HUMANS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS;

MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 64749108284     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.096     Document Type: Article

References (25)

1. Linder M.C., Wooten L., Cerveza P., Cotton S., Shulze R., and Lomeli N. Copper transport. Am. J. Clin. Nutr. 67 (1998) 965S-971S
2. Vulpe C.D., and Packman S. Cellular copper transport. Annu. Rev. Nutr. 15 (1995) 293-322
3. Harris E.D. Basic and clinical aspects of copper. Crit. Rev. Clin. Lab. Sci. 40 (2003) 547-586
4. Armendariz A.D., Gonzalez M., Loguinov A.V., and Vulpe C.D. Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. Physiol. Genomics 20 (2004) 45-54
5. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., and Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271 (1996) 1406-1409
6. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
7. Milward E.A., Papadopoulos R., Fuller S.J., Moir R.D., Small D., Beyreuther K., and Masters C.L. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9 (1992) 129-137
8. Simons A., Ruppert T., Schmidt C., Schlicksupp A., Pipkorn R., Reed J., Masters C.L., White A.R., Cappai R., Beyreuther K., Bayer T.A., and Multhaup G. Evidence for a copper-binding superfamily of the amyloid precursor protein. Biochemistry 41 (2002) 9310-9320
9. Zhang H., Komano H., Fuller R.S., Gandy S.E., and Frail D.E. Proteolytic processing and secretion of human beta-amyloid precursor protein in yeast. Evidence for a yeast secretase activity. J. Biol. Chem. 269 (1994) 27799-27802
10. Ruiz F.H., Gonzalez M., Bodini M., Opazo C., and Inestrosa N.C. Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein. J. Neurochem. 73 (1999) 1288-1292
11. 2+ neurotoxicity in vivo. FASEB J. 18 (2004) 1701-1703
12. Atwood C.S., Scarpa R.C., Huang X., Moir R.D., Jones W.D., Fairlie D.P., Tanzi R.E., and Bush A.I. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75 (2000) 1219-1233
13. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
14. Ancolio K., Dumanchin C., Barelli H., Warter J.M., Brice A., Campion D., Frebourg T., and Checler F. Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 → Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96 (1999) 4119-4124
15. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986) 271-277
16. Tapia L., Gonzalez-Aguero M., Cisternas M.F., Suazo M., Cambiazo V., Uauy R., and Gonzalez M. Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels. Biochem. J. 378 (2004) 617-624
17. Arredondo M., Cambiazo V., Tapia L., Gonzalez-Aguero M., Nunez M.T., Uauy R., and Gonzalez M. Copper overload affects copper and iron metabolism in Hep-G2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G27-G32
18. Sone T., Yamaoka K., Minami Y., and Tsunoo H. Induction of metallothionein synthesis in Menkes' and normal lymphoblastoid cells is controlled by the level of intracellular copper. J. Biol. Chem. 262 (1987) 5878-5885
19. Georgatsou E., and Alexandraki D. Two distinctly regulated genes are required for ferric reduction, the first step of iron uptake in Saccharomyces cerevisiae. Mol. Cell. Biol. 14 (1994) 3065-3073
20. Dancis A., Roman D.G., Anderson G.J., Hinnebusch A.G., and Klausner R.D. Ferric reductase of Saccharomyces cerevisiae: molecular characterization, role in iron uptake, and transcriptional control by iron. Proc. Natl. Acad. Sci. USA 89 (1992) 3869-3873
21. Hassett R., and Kosman D.J. Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae. J. Biol. Chem. 270 (1995) 128-134
22. White A.R., Multhaup G., Maher F., Bellingham S., Camakaris J., Zheng H., Bush A.I., Beyreuther K., Masters C.L., and Cappai R. The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J. Neurosci. 19 (1999) 9170-9179
23. Maynard C.J., Cappai R., Volitakis I., Cherny R.A., White A.R., Beyreuther K., Masters C.L., Bush A.I., and Li Q.X. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277 (2002) 44670-44676
24. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16 (1993) 409-414
25. Treiber C., Simons A., Strauss M., Hafner M., Cappai R., Bayer T.A., and Multhaup G. Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease. J. Biol. Chem. 279 (2004) 51958-51964